温肺止流丹联合西药治疗肺气虚寒型变应性鼻炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R765.21

基金项目:


Clinical Study on Wenfei Zhiliu Pellets Combined with Western Medicine for Allergic Rhinitis of Lung Qi Deficiency-Cold Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察温肺止流丹联合西药治疗肺气虚寒型变应性鼻炎的临床疗效及对血清炎症因子和免疫 功能的影响。方法:采用随机数字表法将84 例肺气虚寒型变应性鼻炎患者分为对照组与观察组各42 例。对照 组给予常规西药治疗,观察组在对照组基础上联用温肺止流丹治疗。比较2 组治疗前后症状积分、血清炎症因 子、血清免疫功能指标,并评估2 组临床疗效及不良反应发生情况。结果:治疗后,观察组总有效率为 95.24%,高于对照组80.95%(P<0.05)。治疗后,2 组鼻部症状积分、眼部症状积分、症状总积分均低于治疗 前(P<0.05),且观察组治疗后鼻部症状积分、眼部症状积分、症状总积分均低于对照组(P<0.05)。治疗 后,2 组治疗后血清白细胞介素(IL) -4、IL-5、IL-17、肿瘤坏死因子-α (TNF-α)、免疫球蛋白(Ig) E、 IgG 及CD8+水平均较治疗前降低(P<0.05),IL-10、IL-35、CD4+水平及CD4+/CD8+升高(P<0.05),且观察 组治疗后血清IL-4、IL-5、IL-17、TNF-α、IgE、IgG 及CD8+水平低于对照组(P<0.05),IL-10、IL-35、 CD4+水平及CD4+/CD8+高于对照组(P<0.05)。观察组不良反应发生率为2.38%,低于对照组19.05% (P< 0.05)。结论:温肺止流丹联合西药治疗肺气虚寒型变应性鼻炎疗效确切,能够明显降低患者炎症反应及改善 免疫功能,安全性较高。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Wenfei Zhiliu Pellets combined with western medicine for allergic rhinitis of lung qi deficiency-cold type and its effect on serum inflammatory factors and immune function. Methods:A total of 84 cases of patients with allergic rhinitis of lung qi deficiency- cold type were divided into the control group and the observation group according to the random nunmber table method, with 42 cases in each group. The control group was treated with routine western medicine, and the observation group was additionally treated with Wenfei Zhiliu Pellets based on the treatment of the control group. Symptom scores,serum inflammatory factors,and serum immune function indexes were compared before and after treatment between the two groups;clinical effects and the incidence of adverse reactions in the two groups were evaluated. Results:After treatment,the total effective rate was 95.24% in the observation group,higher than that of 80.95% in the control group (P<0.05). After treatment,nasal symptom scores, ocular symptom scores, and the total symptom scores in the two groups were lower than those before treatment (P<0.05),and the nasal symptom score,the ocular symptom score,and the total symptom score in the observation group were lower than those in the control group (P<0.05). After treatment, the levels of interleukin (IL)- 4, IL- 5, IL- 17, tumor necrosis factor- α (TNF- α), immunoglobulin (Ig) E,IgG,and CD8 + in serum in the two groups were decreased when compared with those before treatment (P<0.05),and the levels of IL-10,IL-35,CD4+,and CD4+/CD8+ were increased (P<0.05);the levels of IL- 4,IL- 5,IL- 17,TNF- α,IgE,IgG,and CD8 + in serum in the observation group were lower than those in the control group (P<0.05),and the levels of IL-10,IL-35,CD4+,and CD4 +/CD8 + were higher than those in the control group (P<0.05). The incidence of adverse reactions was 2.38% in the observation group, lower than that of 19.05% in the control group (P<0.05). Conclusion: Wenfei Zhiliu Pellets combined with western medicine for allergic rhinitis of lung qi deficiency-cold type has a definite curative effect, and can significantly reduce inflammatory responses and improve immune function,with high safety.

    参考文献
    相似文献
    引证文献
引用本文

尹静,夏清丽.温肺止流丹联合西药治疗肺气虚寒型变应性鼻炎临床研究[J].新中医,2023,55(11):72-76

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-06-16
  • 出版日期:
文章二维码